Author:
Mazurov V. I.,Nasonov E. L.,Lila A. M.,Korolev M. A.,Prystrom A. M.,Kundzer E. V.,Soroka N. F.,Kastanayan A. A.,Povarova T. V.,Plaksina T. V.,Antipova O. V.,Krechikova D. G.,Smakotina S. A.,Tciupa O. A.,Puntus E. V.,Raskina T. A.,Shilova L. N.,Kropotina T. V.,Nesmeyanova O. B.,Popova T. A.,Vinogradova I. B.,Dokukina E. A.,Plotnikova A. V.,Pukhtinskaia P. S.,Zinkina-Orikhan A. V.,Linkova Yu. N.,Eremeeva A. V.,Lutckii A. A.
Reference11 articles.
1. Mazurov, V.I., Zotkin, E.G., Gaydukova, I.Z., et al., Efficacy and safety of levilimab in combination with methotrexate in subjects with rheumatoid arthritis: results of phase II AURORA study, Nauchno-Pract.
Revmatol., 2021, vol. 59, no. 2, pp. 141–151.
2. Mazurov, V.I., Korolev, M.A., Prystrom, A.M., et al., Effectiveness and safety of levilimab in combination with methotrexate in treatment of patients with active rheumatoid arthritis resistant to methotrexate monotherapy (double-blinded randomized placebo-controlled phase III clinical study SOLAR), Sovrem. Revmatol., 2021, vol. 15, no. 4, pp. 13–23.
3. Felson, D.T., Anderson, J.J., Boers, M., Bombardier, C., Furst, D., Goldsmith, C., et al., American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis, Arthritis Rheum., 1995, vol. 38, no. 6, pp. 727–735.
4. van Gestel, A.M., Prevoo, M.L., van’t Hof, M.A., van Rijswijk, M.H., van de Putte, L.B., and van Riel, P.L., Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria, Arthritis Rheum., 1996, vol. 39, no. 1, pp. 34–40.
5. Anderson, J., Caplan, L., Yazdany, J., Robbins, M.L., Neogi, T., and Michaud, K., Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice, Arthritis Care Res. (Hoboken), 2012, vol. 64, no. 5, pp. 640–647.